WILLIS HOLLOWAY: Open Payments
NPI 1023054434 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 38 payments from 12 companies in 2025. Trend: 2023 $1,463 · 2024 $495 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $216 |
| Alkermes, Inc. | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Lundbeck LLC | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: FANAPT, REXULTI, CAPLYTA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, TRINTELLIX, LYBALVI.
Industry payments across OK — which companies pay providers there.
